EGFR ACTIVATING MUTATION
Clinical trials for EGFR ACTIVATING MUTATION explained in plain language.
Never miss a new study
Get alerted when new EGFR ACTIVATING MUTATION trials appear
Sign up with your email to follow new studies for EGFR ACTIVATING MUTATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug duo aims to shrink lung tumors before surgery in targeted therapy trial
Disease control Not yet recruitingThis study tests whether giving a high dose of firmonertinib (a targeted pill) plus bevacizumab (an IV drug that blocks blood vessel growth) before surgery can shrink tumors in people with a specific type of lung cancer (EGFR-mutated, stage II-IIIB). About 62 adults whose cancer …
Matched conditions: EGFR ACTIVATING MUTATION
Phase: PHASE2 • Sponsor: Peking University Cancer Hospital & Institute • Aim: Disease control
Last updated May 17, 2026 05:03 UTC
-
AI could help doctors choose best treatment for lung cancer patients
Knowledge-focused Not yet recruitingThis study looks at data from 1,000 lung cancer patients with a specific gene change (EGFR mutation) who received targeted therapy after surgery. Researchers will use artificial intelligence to analyze CT scans, tissue samples, and genetic reports to see if they can predict which…
Matched conditions: EGFR ACTIVATING MUTATION
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Knowledge-focused
Last updated May 15, 2026 11:56 UTC